Literature DB >> 16598712

TGF beta-mediated RhoA expression is necessary for epithelial-mesenchymal transition in the embryonic chick heart.

André Luiz P Tavares1, Melania E Mercado-Pimentel, Raymond B Runyan, Gregory T Kitten.   

Abstract

Endothelia in the atrioventricular canal (AVC) of the embryonic heart undergo an epithelial-mesenchymal transition (EMT) and migrate into the underlying extracellular matrix. We explore here whether RhoA mediates this EMT. RhoA was detected in all cells of the chick heart during the stages studied. Expression was elevated when EMT was actively occurring. Explants treated with C3 exoenzyme in collagen gel cultures showed a significant decrease in mesenchymal cell numbers. siRNA was used to inhibit RhoA mRNA, and both activated endothelial and mesenchymal cells decreased significantly with treatment. Loss of RhoA produced a reduction of RhoB, cyclin-b2, and beta-catenin messages showing that these genes are regulated downstream of RhoA. In contrast, runx-2 was not reduced. Inhibition of TGFbeta3 or TGFbeta2 activity caused a large reduction of RhoA message. These data place RhoA in TGFbeta regulated pathways for both endothelial activation and mesenchymal invasion and demonstrate a functional requirement during EMT. Developmental Dynamics 235:1589-1598, 2006. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16598712     DOI: 10.1002/dvdy.20771

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  41 in total

Review 1.  Emergence of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin axis in transforming growth factor-β-induced epithelial-mesenchymal transition.

Authors:  Samy Lamouille; Rik Derynck
Journal:  Cells Tissues Organs       Date:  2010-11-02       Impact factor: 2.481

2.  Runx2-I is an Early Regulator of Epithelial-Mesenchymal Cell Transition in the Chick Embryo.

Authors:  Andre L P Tavares; Jessie A Brown; Emily C Ulrich; Katerina Dvorak; Raymond B Runyan
Journal:  Dev Dyn       Date:  2017-07-19       Impact factor: 3.780

3.  MiR-126a-5p is involved in the hypoxia-induced endothelial-to-mesenchymal transition of neonatal pulmonary hypertension.

Authors:  Yan-Ping Xu; Qi He; Zheng Shen; Xiao-Li Shu; Chen-Hong Wang; Jia-Jun Zhu; Li-Ping Shi; Li-Zhong Du
Journal:  Hypertens Res       Date:  2017-02-02       Impact factor: 3.872

4.  Endoglin and Alk5 regulate epithelial-mesenchymal transformation during cardiac valve formation.

Authors:  Melania E Mercado-Pimentel; Antony D Hubbard; Raymond B Runyan
Journal:  Dev Biol       Date:  2006-12-23       Impact factor: 3.582

5.  Discovery of transcription factors and other candidate regulators of neural crest development.

Authors:  Meghan S Adams; Laura S Gammill; Marianne Bronner-Fraser
Journal:  Dev Dyn       Date:  2008-04       Impact factor: 3.780

6.  Sema6D acts downstream of bone morphogenetic protein signalling to promote atrioventricular cushion development in mice.

Authors:  Yin Peng; Lanying Song; Ding Li; Robert Kesterson; Jianbo Wang; Lizhong Wang; Gregg Rokosh; Bingruo Wu; Qin Wang; Kai Jiao
Journal:  Cardiovasc Res       Date:  2016-11-01       Impact factor: 10.787

Review 7.  Molecular mechanisms of epithelial-mesenchymal transition.

Authors:  Samy Lamouille; Jian Xu; Rik Derynck
Journal:  Nat Rev Mol Cell Biol       Date:  2014-03       Impact factor: 94.444

8.  RhoA/ROCK signaling regulates TGFβ-induced epithelial-mesenchymal transition of lens epithelial cells through MRTF-A.

Authors:  Anna Korol; Aftab Taiyab; Judith A West-Mays
Journal:  Mol Med       Date:  2016-09-29       Impact factor: 6.354

9.  Transforming growth factor-beta-stimulated endocardial cell transformation is dependent on Par6c regulation of RhoA.

Authors:  Todd A Townsend; Jeffrey L Wrana; George E Davis; Joey V Barnett
Journal:  J Biol Chem       Date:  2008-03-14       Impact factor: 5.157

10.  Molecular mechanisms of the effect of TGF-β1 on U87 human glioblastoma cells.

Authors:  Igor Bryukhovetskiy; Valeriy Shevchenko
Journal:  Oncol Lett       Date:  2016-06-22       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.